摘要
Elias CHABTINI
企业代表
其他作者: Elias Chabtini
Longevity as a business model: from vision to operational execution
目标: This session provides clinicians and industry leaders with a clear framework to operationalize longevity, transforming it from a buzzword into a repeatable, scalable, and sustainable model aligned with the future of medicine
介绍: Longevity has emerged as one of the most discussed themes in modern healthcare, yet it remains fragmented, often treated as a trend rather than a structured, scalable clinical and business model. This session reframes longevity as an integrated ecosystem, moving from conceptual promise to practical, operational execution within medical practice.
材料 / 方法: The lecture introduces a comprehensive Longevity Ecosystem, illustrating how medical aesthetics, internal wellness, diagnostics, and technology can be orchestrated into a continuous, patient-centric journey. Rather than isolated interventions, longevity is presented as a lifecycle model with defined phases, milestones, and measurable outcomes.
结果: • Consultation: Shifting from aesthetic complaints to intent-driven conversations focused on healthspan, performance, and prevention.
• Diagnosis: Expanding beyond visual assessment to include biomarkers, functional diagnostics, and internal health intelligence.
• Treatment: Integrating medical aesthetics with personalized internal interventions, combining clinical protocols, supplementation, and lifestyle optimization.
• Maintenance: Ensuring sustainability through continuous monitoring, adaptive care plans, and long-term patient engagement.
总结: A central focus of the session is the transition from external aesthetics to internal wellness, positioning aesthetic medicine as the gateway to proactive, preventive, and longevity-focused care. The lecture demonstrates how clinics and healthcare operators can evolve from episodic, reactive models into preemptive, continuous health systems that benefit both patients and providers.
披露 - Elias CHABTINI
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。